GSK wins approval for asthma drug; will be produced in Zebulon
April 30, 2015 at 16:56 PM EDT
GlaxoSmithKline (NYSE: GSK) received approval to market its respiratory drug Breo Ellipta to adult asthma patients...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
